497 / 1031
Reduces
recurrence
31% to
15 4% (N (7287 pts)) and
.
-
63.7% to 42.5% (N+ (1050
pts))
• 10 year gain
15,7% (N-)
and 21,2% (N+)
Reduces breast cancer
mortality
of 20.5% to 17.2%
(N ) and 51 3% to 42 8% (N+)
-
.
.
• 15 year gain
3.3% (N-) and
8 5% (N+)
.